Showing results (11-20 of 93) with videos related to
Sort By:
Pageof 10
Rheumatology (Oxford, England)|March 15, 2023
The diagnostic value of urinary N-terminal fragment of titin for skeletal muscle damage in idiopathic inflammatory myopathyJianhong Sun, Sheng Ye, Geng Yin, et al.Journal of Inflammation (London, England)|November 26, 2024
Macrophage involvement in idiopathic inflammatory myopathy: pathogenic mechanisms and therapeutic prospectsZiqi Li, Huan Liu, Qibing Xie, et al.Heliyon|April 10, 2024
Efferocytosis: Current status and future prospects in the treatment of autoimmune diseasesQianwei Li, Huan Liu, Geng Yin, et al.Journal of Cachexia, Sarcopenia and Muscle|December 10, 2025
Targeted Therapy for Idiopathic Inflammatory MyopathyRuijie Wang, Wei Lin, Qibing Xie, et al.JAMA Network Open|November 22, 2023
Control Groups in RCTs Supporting Approval of Drugs for Systemic Rheumatic Diseases, 2012-2022Yang Liu, Yan Xie, Yunhe Qin, et al.Biochimica Et Biophysica Acta. Reviews on Cancer|May 28, 2026
Understanding tumor heterogeneity: Implications for precision oncology and therapeutic strategiesYinchun Lv, Chenjia He, Qibing Xie, et al.Clinical & Developmental Immunology|October 10, 2013
A clinical analysis of risk factors for interstitial lung disease in patients with idiopathic inflammatory myopathyXiaomin Cen, Chuan Zuo, Min Yang, et al.Rheumatology International|June 18, 2009
Diffuse proliferative glomerulonephritis associated with dermatomyositis with nephrotic syndromeQibing Xie, Yi Liu, Gang Liu, et al.Archives of Rheumatology|October 31, 2018
Serum Interleukin-18 Level is Associated With Disease Activity and Interstitial Lung Disease in Patients With DermatomyositisYuan Yang, Geng Yin, Jingcheng Hao, et al.Therapeutic Advances in Musculoskeletal Disease|January 30, 2025
Identification of clinical subgroups in anti-SRP positive immune-mediated necrotizing myopathy patients using cluster analysisBeibei Cui, Hongjiang Liu, Ruiting Liu, et al.Pageof 10